6Villers D , Espaze E , Coster Burel M . Nosocomial Acinetobacter baumannii infections. Microbiological and clinical epidemiology[J]. Ann Intern Med, 1998,129(3): 182.
7ManuelW , Ziad A , Larson E , et al. Outbreak of Acinetobacter baumannii in an intensive care unit associated with tracheotomy[J]. Am Infect Control ,2001,29(5) :284.
8Lortholary O, Fagon J Y, Hoi A B, et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii:risk factors and prognosis [J]. Clin Infect Dis, 1995,70(3) :790.
9Okpara A U, Moswoswe J J. Emergence of multidrugresistant isolates of Acinetobacter baumannii [J]. Am J Hos Pharm, 1994, 51(21): 21671.
10Siham M, Jimmie X, Wurts R, et al. Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii [J]. Am J Infect Control,2002, 30(7): 386.
7Higuchi T.Mechanism of sustaineducation mediation. Theoretical analysis of redeosc of sdid drugs dispersed in solid matrics[J].J Pham Sci, 1963, 52 :1145-1149.
8Bou G, Cervero G, Dominguez MA, et al. Character2ization of a nosocomial outbreakcaused by a multire2sistant Acinetobacter baumannii strain with a carbap2enem2hy- drolyzing enzyme: high21evel carbapenem resistance in A. baum annii is not due solely to the ores2ence of β- lactamases[J].J ClinMicrobiol, 2000,38:3299-3305.
